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Angiotensin Converting Enzyme (ACE) is a zinc metallopeptidase that has a 
significant role in blood pressure regulation and the pathophysiology of 
hypertension. ACE has two protein domains, the N-domain and the C-domain, which 
each has a single active site that functions independently of each other. There is 
insertion/deletion by 288 bp Alu elements in the intron 16 of ACE gene. The Alu 
elements potentially alter splicing process. The effect of the insertion of Alu elements 
in the splicing pattern of the ACE gene has not been reported. Here, we report on the 
results of splicing pattern analysis of the ACE gene due to the insertion of Alu 
elements. Using an in-silico approach, we found the presence of Alu elements 
insertion in intron 16 of ACE caused alternative splicing and experienced 
exonization. Further analysis showed that the exonization lead to a premature 
termination codon (PTC), which is raised protein shortening and lost one of its two 
protein domains. The loss of one protein domain may affect the catalytic activity of 
ACE. These findings suggest that the Alu elements I/D polymorphism is related to 
the differences in the catalytic activity of ACE that may influence blood pressure 
regulation and hypertension. 
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1. INTRODUCTION 
Hypertension is a cardiovascular disease suffered by 30% of the global population[1]. This disease is 
caused by multiple factors including the level of salt intake, kidney conditions, stress, genetics, obesity, and 
endothelial circumstances[2]. In general, blood pressure is regulated by the renin-angiotensin system (RAS) and 
kallikrein-kinin system (KKS)[3]. Angiotensin Converting Enzyme (ACE) is an enzyme that serves a crucial 
role in the RAS and KKS. In the RAS, ACE assists the conversion of the inactive decapeptide Angiotensin I 
(Ang I) into the active octapeptide Angiotensin II (Ang II), a vasoconstrictor. In KKS, ACE plays a role in the 
inactivation of bradykinin (BK), a vasodilator[3]–[8]. 
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ACE gene is 21 kb long, is located on the chromosome 17q23. ACE gene is consisting of 26 exons and 
25 introns[6]. There is an insertion/deletion polymorphism in the intron 16 of ACE, characterised by the 
presence (insertion, I) or absence (deletion, D) of 288 bp Alu elements[7]. Alu elements are DNA repeat 
sequences, the group of Short Interspersed elements (SINE)[9]. In some genes, the insertion of Alu elements 
causes alternative splicing and results in exonization (the creation of cryptic exons)[10], [11]. Exonization can 
produce the mRNA transcripts to become longer, but such effects are not always applicable to the protein 
product. Exonization can cause a premature termination codon (PTC), resulting in protein shortening. 
ACE with Alu elements insertion (ACE I) is believed to undergo protein shortening so that its 
molecular weight is lower than that of ACE Deletion (ACE D), which affects its activity. This phenomenon is 
corresponding with findings of Fuch et al. And Agerholm et al.[12], [13], ACE I activity is lower than that of 
ACE D.  
ACE consists of two protein domains, the C-domain and the N-domain. Each domain has one active 
site that works independently of each other[12]. The Alu elements insertion may lead to protein shortening that 
causes loss of one active site in C-domain. For this reason, ACE I catalytic activity is not as high as that of ACE 
D. The low catalytic activity of ACE I in the conversion of Ang I to Ang II impacts the level activity of 
vasoconstriction. Therefore, this polymorphism is believed to have a huge effect on the structure and activity of 
the ACE protein. This study was conducted to determine the impact of Alu elements insertion to the splicing 
pattern of ACE and the 3D structure of its protein using the in-silico approach. 
2. MATERIALS AND METHODS 
2.1. Searching for the exonization of Alu elements in the GenBank database 
According to data from GenBank, there are only three variant transcripts of ACE mRNA. Therefore, 
we have search transcript of any genes that contain Alu elements sequence.  We used part of the Alu elements 
sequence (CGGGATGGTCTCGATCTCCTGACCTCGTGATCCGCCCGCCTCGGCCTC) to conduct a blast 
search in the ref_seq RNA NCBI database (http://blast.ncbi.nlm.nih.gov/Blast.cgi). All of these transcripts of 
cDNA sequences were saved in FASTA format.  Individually of all variant were aligned with Alu elements, its 
genomic DNA and all variant of the transcript for each gene by ClustalW (Bioedit7.1.9). 
We found over than five thousand transcripts that contain Alu elements. However, only 297 genes have 
inserted by Alu elements in the intron. Further, we focused on nine genes that inserted by Alu elements in the 
intron and have the definite motif of exonization (Table 1).  This was done to identify the exonization of Alu 
elements in the cDNA transcripts was occurred in nature (GenBank). 
 
2.2. Examination of HSF accuracy  
The accuracy of Human Splicing Finder (HSF) 2.4.1 webserver software[14] for splicing pattern 
analysis was examined using known splicing data of the nine genes. The test was performed by inserting 
sequences that contain intron-exon-intron junctions of the genes with exonized Alu elements that have known 
splicing pattern and exonization locations. We also included 100 bases of the downstream intron and 100 bases 
of the upstream intron of an exon derived from Alu elements. HSF then scored the consensus value (CV) of 
every splice site it found. The splice site with the highest CV that is above the cut-off value is the most likely 
splice site. The cut off for the human 3' splice site is 75, and for the 5' splice site, it is 78[15]. Then we compare 
the HSF result (highest CV score) with the real data (transcripts) from the GenBank. The validity of HSF 
software was a test based on the outcome of the prediction is same with the real data.  
 
2.3. Splicing pattern analysis of Alu elements inserted in intron 16 ACE  
The splicing pattern due to Alu elements insertion in intron 16 ACE was analysed using HSF[14]. HSF 
identify and determine the potential splice sites through the method of the consensus value (CV) scoring. CV is 
the accuracy percentage of splice site base recognition by the spliceosome. CV values ranged from 0 (consensus 
with the worst recognition) to 100 (consensus with the best recognition). Splice sites are categorised according 
to whether their CV scores are above the cut-off. For human genes, the cut off is 78 for 5' ss, with a mean of 82, 
and 75 for 3' ss with an average of 80[15]. The potential splice sites were chosen based on the CV scores that 
were above the cut-off values. The splicing patterns of ACE intron 16 Alu elements that have been obtained by 
HSF software were then used to determine the cryptic exon sequence (exon derived from the Alu elements). 
These cryptic exons were then inserted between exon 16 and exon 17 in a somatic ACE CDS sequence 
(consisting of exon 1 to exon 25) using Bioedit 7.1.9 software. Further, the transcript sequence translated into 
amino acid sequences using the FR33 webserver (http://www.fr33.net/translator.php). Then we construct the 
three-dimensional structure of the ACE based on the splicing pattern.   
 
2.4. Protein modelling and physicochemical analysis 
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Protein structure of ACE I and ACE D were constructed using threading modelling using I-
TASSER[16]–[18]. The physicochemical profiles of ACE proteins, including molecular weight, number and 
composition of amino acid sequences, were analysed by the Expasy Protparam tool webserver 
(web.expasy.org/protparam). 
 
3. RESULTS AND DISCUSSION 
Alu elements are the most abundant DNA repeat sequences from the Short Interspersed Elements 
(SINEs) group in primate genes. Alu elements make up not less than 10% of the mass of the human genome[19]. 
Cryptic splice site activation can result in alternative splicing and exonization so that a single gene can produce 
more than one mRNA transcript variant. 
Approximately 400 of the 30,000 human genes that contain Alu elements are exonized in the coding 
region[20]. Through blast searching, we found that at least 5.000 cDNA transcripts of primates were indicated to 
have experienced exonization. Through ClustalW multiple alignments (Bioedit7.1.9), we aligned mRNA 
(cDNA) and DNA sequences of these 5.000 genes, individually, with Alu elements of ACE intron 16. We found 
no less than 407 cDNA transcripts of 297 primate genes having exonization. There are Homo sapiens (295 
mRNA transcripts and 76 transcripts of non-coding RNA), Pongoabelii (27 mRNA transcripts), Pantroglodytes 
(3 mRNA transcripts), Macacamulata (5 mRNA transcripts), and Callithrixjacchus (1 mRNA transcript). Most 
of the exonisation on the transcript that we analysed occurred at the 3'and 5' UTR, and the whole sequence of 
Alu elements were exonized. For this reason, the splicing patterns were unclear. However, from these 407 cDNA 
transcripts, there were nine transcripts with partly exonised Alu elements with identical splicing pattern (Table 
1), especially the acceptor splice site (5'ss). Thus, this is evidence that Alu elements were potentially becoming 
exonised. 
To analyse the splicing pattern of ACE intron 16 with Alu elements insertion, we tested the Human 
Splicing Finder (HSF) webserver. Before using the HSF for Alu splicing pattern analysis, we checked its 
accuracy with the recognition and scoring of the splicing pattern of Alu elements in the genes with known 
splicing patterns. As a result, the HSF correctly assigned some cryptic splice sites, which is the highest CV score 
for potential splice sites has same with transcript sequence from GenBank. 
 
Table 1. mRNA and non-coding RNA with identical Alu elements splicing patterns 
No 
RNA accession 
number 
Description 
Position of Alu 
exonization 
Acceptor splice site 
motif 
Donor splice 
site motif 
1 NM_001131028.1 
Homo sapiens autophagy-related 10 
(ATG10), transcript variant 3, mRNA 
Exon 2 
(283...417) 
ttgtatttttagTA 
(79,84)* 
AAGgtaggc 
(88,53)* 
2 NM_001257399.1 
Homo sapiens ubiquitin-conjugating 
enzyme E2 variant 1 (UBE2V1), transcript 
variant 11, mRNA 
Exon 5 Var 11 
(93...210) 
ttgtatttttagTA 
(79,84)* 
CAGgtatgt 
(91,2)* 
3 NM_001146310.1 
Homo sapiens chromosome 1 open reading 
frame 86 (C1orf86), transcript variant 1, 
mRNA 
Exon - var 1 
(179..331) 
ttgtatttttagTA 
(79,84)* 
ACGgtaggt 
(85,96)* 
4 NR_026773.1 
Homo sapiens chromosome 6 open reading 
frame 123 (C6orf123), non-coding RNA 
Exon 4 
(693..1652) 
ttgtatttttagTA 
(79,84)* 
Last exon 
5 NM_145326.2 
Homo sapiens zinc finger protein 493 
(ZNF493), transcript variant 2, mRNA 
Exon 4 var 2 
(376..1702) 
ttgtattttcagTA 
(87,52)* 
Last exon 
6 NM_005426.2 
Homo Sapien's tumour protein p53 binding 
protein, 2 (TP53BP2), transcript variant 2, 
mRNA 
Exon 3 var 2 
(468..599) 
ttgtatttttagTA 
(79,84)* 
AAGgtaata 
(84,39)* 
7 NM_031451.4 
Homo sapiens testis expressed 101 
(TEX101), transcript variant 1, mRNA 
Exon 3 var 1 
(186..279) 
tgtattttttagTA 
(78,03)* 
CAGgtatga 
(88,86)* 
8 NR_024271.1 
Homo sapiens septin 7 pseudogene 2 
(SEPT7P2), non-coding RNA 
Exon 10 
(1160..1354) 
tttttttttcagTA 
(92,59)* 
TAGgtatgg 
(74,96)* 
9 NM_001270393.1 
Homo sapiens protein kinase (cAMP-
dependent, catalytic) inhibitor beta 
(PKIB), transcript variant 4, mRNA 
Exon - var 4 
(215..334) 
tatttttggtagAG 
(78,74)* 
AAGgtaagt 
(99,05)* 
* ConsensusValue(CV) score 
 
HSF was then used to analyse the splicing pattern of ACE intron 16 Alu elements. Based on this method, it 
was found that ACE may potentially experience the alternative splicing, and we found six possible splicing 
patterns (Table 2). Alternative splicing is a mechanism of gene regulation in which the use of alternative splice 
sites in the splicing process generates multiple mRNA products from a single gene. This mechanism works to 
develop variations of the proteome. According to Desmet et al.[14], exon and intron existence is not static. 
Mutations in the gene can affect the spliceosomes in recognising the splice sites[14], resulting in alternative 
splicing. One type of alternative splicing is intron retention, called exonization. Exonization is the process by 
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which genes acquire a new exon from the non-protein-coding sequence, mainly derived from introns. It is 
estimated that approximately 60% of human genes have alternative splicing[14]. 
 
 
 
 
 
 
 
 
 
Figure 1. 3D structures of predicted protein modelling of ACE 
proteins. (a) ACE D; (b) Model 1 of ACE I; (c) Model 2 of ACE 
I; (d) Model 3 of ACE I; (e) Model 4 of ACE I; (f) Model 5 of 
ACE I; (g) Model of ACE I. Overall the ACE proteins are 
experiencing protein shortening and the loss of the C-
domain.The green colour indicates the ACE proteins which are 
not affected by the insertion and the exonization of Alu 
elements; the red colour indicates additional protein due to the 
insertion and exonization of Alu elements. ACE D protein (a) is 
not influenced by both addition or reduction of amino acids, 
whereas ACE I (b, c, d, e, f, g) undergoes not only having 
protein shortening, but also the addition of amino acids (red).
 
 
Table 2. The six possible splicing patterns of ACEintron 16 Alu elements 
Cons. Seq ACE D ACE I (1) ACE I (2) ACE I (3) ACE I (4) ACE I (5) ACE I (6) 
Upstream intron 5’ ss 
(score) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
CAGgtgaga 
(96,51) 
Upstream intron BP 
(position) 
- ggctaAt 
(-17) 
ggctaAt 
(-17) 
ggctaAt 
(-17) 
GgctaAt 
(-17) 
ggctaAt 
(-17) 
GgctaAt 
(-17) 
Upstream intron 3’ ss 
(score) 
- ctcctgcctcagCC 
(87,06) 
ctgggaccacagCG 
(81,25) 
TtgtatttttagTA 
(79,84) 
ctgggattacagGC 
(85,4) 
attttattccagCT 
(88,65) 
CcttacaagcagAG 
(82,97) 
Downstream intron 5’ ss 
(score) 
- GAGgtgagc 
(94,91) 
GAGgtgagc 
(94,91) 
GAGgtgagc 
(94,91) 
GAGgtgagc 
(94,91) 
GAGgtgagc 
(94,91) 
GAGgtgagc 
(94,91) 
Downstream intron BP agctcAa agctcAa agctcAa agctcAa AgctcAa agctcAa AgctcAa 
a. 
b. 
d. 
c. 
f. 
g. 
e. 
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(position) (-22) (-22) (-22) (-22) (-22) (-22) (-22) 
Downstream intron 3’ 
splice site (score) 
aaccccctaccagAT 
(85,57) 
aaccccctaccagAT 
(85,57) 
aaccccctaccagAT 
(85,57) 
aaccccctaccagAT 
(85,57) 
aaccccctaccagAT 
(85,57) 
aaccccctaccagAT 
(85,57) 
AaccccctaccagAT 
(85,57) 
BP = Branch Point; ss= splice site; 
 
We got six exonization models of ACE based on the splicing pattern analysis described above (Table 
3). At first glance, the presence of exonized Alu elements extended the CDS sequences. However, after being 
translated into amino acids, the sequences exhibited premature termination codons (PTC), which entailed 
enabling the protein shortening. ACEconsists of two protein domains, the C-domain and the N-domain; there is 
an active site that works independently in each domain[12]. Due to this protein shortening, the six models of 
ACE I proteins lost the large quantities of amino acids that constituted the C-domains. The phenomenon of 
protein shortening was discovered by Sorek et al. after they investigated the effects of Alu elements insertion in 
the protein coding region of several genes[20]. Their finding showed that 84% of exonized Alu elements that 
occupied protein-coding regions caused protein shortening through either frameshift or inframe stop codon 
mechanisms. 
 
Table 3. Length of CDS Transcripts and protein profile of ACE D and ACE I models 
Model 
CDS sequence length without 
Alu exonization (base) 
Alu exonization length 
(base) 
CDS sequence length 
with Alu (base) 
PTC 
Position 
Amino Acid 
sequence (residues) 
MW of ACE 
Proteins (kDa) 
ACE D 3921 - 3921 1307 1306 149,7 
ACE I (Model 1) 3921 237 4158 784 783 89,3 
ACE I (Model 2) 3921 213 4134 776 775 88,6 
ACE I (Model 3) 3921 174 4095 787 786 90,0 
ACE I (Model 4) 3921 80 4001 797 796 90,9 
ACE I (Model 5) 3921 35 3956 782 781 89,4 
ACE I (Model 6) 3921 2 3923 771 770 88,2 
PTC = Premature Termination Codon 
 
Based on threading modelling results, protein shortening showed significant differences in the 3D 
structure and physicochemical profile of ACE D and the six models of the ACE I (Figure 1 and Table 3). Due to 
the loss of large number of amino acids, ACE I had a lower molecular weight than that of ACE D, thus affecting 
the level and concentration of plasma ACE. This is by the findings of Smithies et al., in which the plasma 
concentration in subjects with the ACE II genotype was only 60% of the plasma concentration of the ACE DD 
genotype. Another effect of the protein shortening on ACE I was the loss of one active site. Consequently, ACE 
I activity to convert Ang I to Ang II is not as high as ACE D. This data explained the reason of subjects with the 
DD genotype has risk factors for hypertension higher than subjects with ID and II genotypes[21]. In addition, it 
has been reported that hypertensive patients with genotype II are hypersensitive to dry cough induced by the 
administration of ACE-inhibitors[22]. The low activity of ACE I in the Bradykinin inactivation leads to the 
accumulation of Bradykinin. The accumulation of Bradykinin in the lungs causes the activation of 
proinflammatory peptides (substance P, prostaglandins, neuropeptideY, and phospholipases C and A2) and the 
local liberation of histamine in the airway, with the consequence of stimulating of vagal afferent[23], [24]. A 
cough reflex follows the stimulation mechanism. Prostaglandins and histamine that are released as a result of 
Bradykinin accumulation also cause hypersensitivity to cough[24]. Thus, I /D polymorphism causes ACE gene 
splicing pattern variation. This impacts the protein profile of their products and subsequently affect ACE 
activity in the pathophysiology of hypertension and ACE inhibitor-induced cough. However, further research is 
required to collect the necessary data to investigate the effect of the Alu elements insertion in intron16 ACE by 
sequencing the cDNA, also the effect of other gene such as Bradykinin B2 Receptor[25]. 
 
4. CONCLUSION 
Based on our research, Alu elements I/D polymorphism in intron 16 of ACE causes alternative splicing that 
impacts on the transcriptome variation. The Alu element insertion caused exonisation that implicated to protein 
shortening of ACE. The truncated ACE protein in one of the active site might reduce its activity.   
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